The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2025

Filed:

Jan. 26, 2023
Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Jayaraman Chandrasekhar, Redmond, WA (US);

Jonah J. Chang, Woodinville, WA (US);

Kevin S. Currie, North Bend, WA (US);

Stephen D. Holmbo, Kirkland, WA (US);

Jesse M. Jacobsen, Seattle, WA (US);

David L Kukla, Newcastle, WA (US);

Seung H. Lee, Sammamish, WA (US);

Yasamin Moazami, Seattle, WA (US);

Leena B. Patel, Seattle, WA (US);

Thomas J. Paul, Snohomish, WA (US);

Stephane Perreault, Brier, WA (US);

Patrick J. Salvo, Burien, WA (US);

Jennifer A. Treiberg, Redmond, WA (US);

Heath A. Weaver, Seattle, WA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 491/107 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/107 (2013.01); C07D 495/04 (2013.01); C07D 498/04 (2013.01);
Abstract

Provided herein is a compound of Formula I: or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or deuterated analog thereof, a pharmaceutical composition comprising a compound of the present invention, together with a pharmaceutically acceptable excipient thereof, and a method of treating cancer with the same.


Find Patent Forward Citations

Loading…